Delivery Order SPE2DB24D3015-SPE2DB25FFXPL
Award Date
1/3/25
Potential Completion Date
1/6/25
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $9,639.90 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GRALISE ER 600 MG TABLET 90S, a prescription medication. The award has an ultimate completion date of July 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a for-profit pharmaceutical distribution company. The $1,740.27 firm fixed price contract is for the supply of GRALISE ER 600 MG TABLET 90S, a prescription medication. The delivery order was issued under an existing indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,627.35 firm fixed-price contract is for the delivery of GRALISE ER 300 MG TABLET 90S, a pharmaceutical product. The award has an ultimate completion date of August 10, 2022.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The U.S. Defense Logistics Agency (DLA) awarded a $4,578.64 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GRALISE ER 300 MG TABLET 90S. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GRALISE ER 300 MG TABLET 90S. The $2,289.32 firm fixed-price contract has a completion date of July 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a comprehensive vehicle for providing a range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,445.15, is for the delivery of GRALISE ER 600 MG tablets, a medication used in the treatment of neuropathic pain. The contract has a completion date of September 10, 2024 and is a firm fixed-price contract. The place of performance is Conshohocken, PA. AmerisourceBergen is a for-profit organization registered in the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of GRALISE ER 600 MG TABLET 90S, a prescription pharmaceutical product. The contract has a firm fixed price of $4,989.19 and a completion date of September 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, which enables the agency to efficiently procure a wide range of medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of Gralise ER 600 mg tablets, a medication used for the treatment of neuropathic pain. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $6,970.45 and an ultimate completion date of April 25, 2024. AmerisourceBergen, a for-profit organization, is the prime contractor, and the contract does...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of GRALISE ER 300 MG TABLET 90S. The contract has a completion date of February 15, 2024 and a potential value of $1,716.99. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of GRALISE ER 600 MG TABLET 90S, a prescription drug product, with a total ceiling value of $4,162.48. The contract has a firm fixed price pricing type and is set to expire on September 19, 2024. This award is not associated with a set-aside program. Amerisourcebergen, through its Corporate...